Dr Marjorie Green, head of global clinical development, oncology, at Merck Research Labs, said the subcutaneous route "has the potential to improve the patient experience as well as increase ...

Subject to confirmation in larger trials, these differences in darbepoetin alfa dosing requirements might make intravenous administration more cost-efficient than the subcutaneous route.

Although the intramuscular route is commonly used for administering human vaccines, subcutaneous, intraperitoneal and intramuscular routes are often used interchangeably for immunizing ...

The FDA approved subcutaneous Opdivo for solid tumors, providing a more convenient treatment option that reduces time toxicity and enhances patient accessibility. Subcutaneous administration allows ...

The subcutaneous formulation of Opdivo provides a convenient alternative to intravenous administration for patients with solid tumors, maintaining efficacy and safety. The CHECKMATE-67T trial ...